Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Cardiovascular effects of pioglitazone or sulphonylureas according to pretreatment risk: moving towards personalized care.

Vaccaro O, Lucisano G, Masulli M, Bonora E, Del Prato S, Rivellese AA, Giorda CB, Mocarelli P, Squatrito S, Maggioni AP, Riccardi G, Nicolucci A; TOSCA.IT investigators.

J Clin Endocrinol Metab. 2019 May 6. pii: jc.2019-00361. doi: 10.1210/jc.2019-00361. [Epub ahead of print]

PMID:
31058962
2.

Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study.

Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, Perriello G, Squatrito S, Buzzetti R, Sartore G, Babini AC, Gregori G, Giordano C, Clemente G, Grioni S, Dolce P, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Nutrients. 2018 Aug 10;10(8). pii: E1067. doi: 10.3390/nu10081067.

3.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917544
4.

Seasonal variations in TSH serum levels in athyreotic patients under L-thyroxine replacement monotherapy.

Gullo D, Latina A, Frasca F, Squatrito S, Belfiore A, Vigneri R.

Clin Endocrinol (Oxf). 2017 Aug;87(2):207-215. doi: 10.1111/cen.13351. Epub 2017 May 16.

PMID:
28398655
5.

Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.

Russo M, Malandrino P, Moleti M, D'Angelo A, Tavarelli M, Sapuppo G, Giani F, Richiusa P, Squatrito S, Vigneri R, Pellegriti G.

Anticancer Res. 2017 Mar;37(3):1515-1522.

PMID:
28314327
6.

Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study.

Vitale M, Masulli M, Rivellese AA, Bonora E, Cappellini F, Nicolucci A, Squatrito S, Antenucci D, Barrea A, Bianchi C, Bianchini F, Fontana L, Fornengo P, Giorgino F, Gnasso A, Mannucci E, Mazzotti A, Nappo R, Palena AP, Pata P, Perriello G, Potenziani S, Radin R, Ricci L, Romeo F, Santini C, Scarponi M, Serra R, Timi A, Turco AA, Vedovato M, Zavaroni D, Grioni S, Riccardi G, Vaccaro O; TOSCA.IT Study Group.

Eur J Nutr. 2018 Mar;57(2):679-688. doi: 10.1007/s00394-016-1355-1. Epub 2016 Dec 21.

PMID:
28004268
7.

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study.

Vitale M, Vaccaro O, Masulli M, Bonora E, Del Prato S, Giorda CB, Nicolucci A, Squatrito S, Auciello S, Babini AC, Bani L, Buzzetti R, Cannarsa E, Cignarelli M, Cigolini M, Clemente G, Cocozza S, Corsi L, D'Angelo F, Dall'Aglio E, Di Cianni G, Fontana L, Gregori G, Grioni S, Giordano C, Iannarelli R, Iovine C, Lapolla A, Lauro D, Laviola L, Mazzucchelli C, Signorini S, Tonutti L, Trevisan R, Zamboni C, Riccardi G, Rivellese AA; TOSCA.IT Study Group.

Clin Nutr. 2017 Dec;36(6):1686-1692. doi: 10.1016/j.clnu.2016.11.002. Epub 2016 Nov 14.

PMID:
27890487
8.

Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.

Malandrino P, Russo M, Regalbuto C, Pellegriti G, Moleti M, Caff A, Squatrito S, Vigneri R.

Thyroid. 2016 Sep;26(9):1285-92. doi: 10.1089/thy.2016.0168. Epub 2016 Jul 22.

PMID:
27349273
9.

Metastatic malignant struma ovarii with coexistence of Hashimoto's thyroiditis.

Russo M, Marturano I, Masucci R, Caruso M, Fornito MC, Tumino D, Tavarelli M, Squatrito S, Pellegriti G.

Endocrinol Diabetes Metab Case Rep. 2016:160030. doi: 10.1530/EDM-16-0030. Epub 2016 May 21.

10.

A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma.

Scollo C, Russo M, De Gregorio L, Terranova R, Mangione E, Castoro C, Squatrito S, Pellegriti G.

Endocr J. 2016;63(1):87-91. doi: 10.1507/endocrj.EJ15-0399. Epub 2015 Oct 24.

11.

Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination.

Malandrino P, Russo M, Ronchi A, Minoia C, Cataldo D, Regalbuto C, Giordano C, Attard M, Squatrito S, Trimarchi F, Vigneri R.

Endocrine. 2016 Aug;53(2):471-9. doi: 10.1007/s12020-015-0761-0. Epub 2015 Oct 5.

PMID:
26438396
12.

Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update.

Tumminia A, Sciacca L, Frittitta L, Squatrito S, Vigneri R, Le Moli R, Tomaselli L.

Patient Prefer Adherence. 2015 Sep 7;9:1263-70. doi: 10.2147/PPA.S69482. eCollection 2015. Review.

13.

Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families.

Tavarelli M, Russo M, Terranova R, Scollo C, Spadaro A, Sapuppo G, Malandrino P, Masucci R, Squatrito S, Pellegriti G.

Front Endocrinol (Lausanne). 2015 Aug 3;6:117. doi: 10.3389/fendo.2015.00117. eCollection 2015.

14.

Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.

Russo M, Scollo C, Pellegriti G, Cotta OR, Squatrito S, Frasca F, Cannav├▓ S, Gullo D.

Clin Endocrinol (Oxf). 2016 Apr;84(4):614-9. doi: 10.1111/cen.12868. Epub 2015 Aug 18.

PMID:
26221968
15.

Several Site-specific Cancers are Increased in the Volcanic Area in Sicily.

Russo M, Malandrino P, Addario WP, Dardanoni G, Vigneri P, Pellegriti G, Squatrito S, Vigneri R.

Anticancer Res. 2015 Jul;35(7):3995-4001.

PMID:
26124347
16.

Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.

Tumminia A, Crimi S, Sciacca L, Buscema M, Frittitta L, Squatrito S, Vigneri R, Tomaselli L.

Diabetes Metab Res Rev. 2015 Jan;31(1):61-8. doi: 10.1002/dmrr.2557.

PMID:
24816997
17.

Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression.

Sciacca L, Cassarino MF, Genua M, Vigneri P, Giovanna Pennisi M, Malandrino P, Squatrito S, Pezzino V, Vigneri R.

J Cell Physiol. 2014 Nov;229(11):1817-21. doi: 10.1002/jcp.24635.

PMID:
24683100
18.

Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling.

Malaguarnera R, Sacco A, Morcavallo A, Squatrito S, Migliaccio A, Morrione A, Maggiolini M, Belfiore A.

Endocrinology. 2014 Apr;155(4):1207-21. doi: 10.1210/en.2013-1925. Epub 2014 Jan 17.

19.

Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R.

J Cancer Epidemiol. 2013;2013:965212. doi: 10.1155/2013/965212. Epub 2013 May 7.

20.

Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients.

Genovese S, Passaro A, Brunetti P, Comaschi M, Cucinotta D; PRISMA study group, Egan CG, Chinea B, Bravi F, Di Pietro C.

J Endocrinol Invest. 2013 Sep;36(8):606-16. doi: 10.3275/8895. Epub 2013 Mar 19.

PMID:
23511244

Supplemental Content

Loading ...
Support Center